Cargando…

Pre-treatment (18)F-choline PET/CT is prognostic for biochemical recurrence, development of bone metastasis, and cancer specific mortality following radical local therapy of high-risk prostate cancer

BACKGROUND: The aim of this study was to determine whether lymph node metastasis on pre-treatment (18)F-choline PET/CT is an independent prognostic factor for biochemical recurrence (BCR), skeletal metastasis, and cancer specific mortality (CSM), after radical local treatment (radical prostatectomy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kjölhede, Henrik, Almquist, Helén, Lyttkens, Kerstin, Bratt, Ola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097795/ https://www.ncbi.nlm.nih.gov/pubmed/30148254 http://dx.doi.org/10.1186/s41824-018-0034-2

Ejemplares similares

Prospective Comparison of F-18 Choline PET/CT Scan Versus Axial MRI for Detecting Bone Metastasis in Biochemically Relapsed Prostate Cancer Patients
por: Huysse, Wouter, et al.
Publicado: (2017)

COVID-19 pneumonia: increased choline uptake with 18F-choline PET/CT
por: Olivari, Laura, et al.
Publicado: (2020)

Choline PET/CT in recurrent prostate cancer
por: Detti, Beatrice, et al.
Publicado: (2023)

Clinical Indications of (11)C-Choline PET/CT in Prostate Cancer Patients with Biochemical Relapse
por: Picchio, Maria, et al.
Publicado: (2012)

Optimising (18)F-Choline PET/CT Acquisition Protocol in Prostate Cancer Patients
por: Massaro, Arianna, et al.
Publicado: (2012)

Cerebellar Metastases from Prostate Cancer Detected by PET/CT with (18)F-Choline
por: Filippi, Luca, et al.
Publicado: (2022)

The Diagnostic Role of (18)F-Choline, (18)F-Fluciclovine and (18)F-PSMA PET/CT in the Detection of Prostate Cancer With Biochemical Recurrence: A Meta-Analysis
por: Wang, Rang, et al.
Publicado: (2021)

Interpretation of 11C–choline PET/CT for the diagnosis of local relapse in radically treated prostate cancer
por: Matti, A., et al.
Publicado: (2017)

Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer
por: Schwarzenböck, S., et al.
Publicado: (2012)

18F-Choline PET/CT or PET/MR and the evaluation of response to systemic therapy in prostate cancer: are we ready?
por: Urso, Luca, et al.
Publicado: (2022)

Imaging Comparison between (18)F-FDG-PET/CT and (18)F-Flouroethyl Choline PET/CT in Rare Case of Thymus Carcinoma Exhibiting a Positive Choline Uptake
por: Takesh, Mustafa, et al.
Publicado: (2013)

Tiny Obturator Node Metastasis from Prostate Cancer Not Shown by FDG-PET/CT, CT, or MRI Detected by (11)C-Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2018)

Effect of positive carbon-11-choline PET/CT results in the therapeutic management of prostate cancer biochemical relapse
por: Gómez-de la Fuente, Francisco J., et al.
Publicado: (2019)

Role of (18)F-choline PET/CT in evaluation of patients with prostate carcinoma
por: Hodolic, Marina
Publicado: (2010)

Choline PET/CT in Multiple Myeloma
por: Mesguich, Charles, et al.
Publicado: (2020)

Evaluation of (18)F-PSMA-1007 PET/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy
por: Zhou, Xing, et al.
Publicado: (2021)

Metastasis-Directed Radiotherapy for Oligoprogressive Castration-Resistant Prostate Cancer Recurrence Revealed by Choline PET/CT
por: Kitajima, Kazuhiro, et al.
Publicado: (2021)

PET/CT analysis of 21 patients with breast cancer: physiological distribution of (18)F-choline and diagnostic pitfalls
por: Ahmad Saad, Fathinul Fikri, et al.
Publicado: (2018)

(18)F–Choline PET/CT Identifies High-Grade Prostate Cancer Lesions Expressing Bone Biomarkers
por: Urbano, Nicoletta, et al.
Publicado: (2019)

The Role of [(18)F]Fluciclovine PET/CT in the Characterization of High-Risk Primary Prostate Cancer: Comparison with [(11)C]Choline PET/CT and Histopathological Analysis
por: Zanoni, Lucia, et al.
Publicado: (2021)

Head-to-Head Comparison of [(18)F]F-choline and Imaging of Prostate-Specific Membrane Antigen, Using [(18)F]DCFPyL PET/CT, in Patients with Biochemical Recurrence of Prostate Cancer
por: García-Zoghby, Laura, et al.
Publicado: (2023)

(18)F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature
por: Evangelista, Laura, et al.
Publicado: (2020)

The Added Value of [(18)F]Choline PET/CT in Low-Risk Prostate Cancer Staging: A Case Report
por: Piras, Antonio, et al.
Publicado: (2022)

Detection Efficacy of (18)F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy
por: Giesel, Frederik L., et al.
Publicado: (2019)

An Incidental Pancreatic Finding at 18F-Choline PET/CT: Chronic Mass-Forming Pancreatitis
por: Evangelista, Laura, et al.
Publicado: (2021)

Study of inter- and intra-observer reproducibility in the interpretation of [(18)F]choline PET/CT examinations in patients suffering from biochemically recurrent prostate cancer following curative treatment
por: Pegard, Clothilde, et al.
Publicado: (2014)

Diagnostic performance of choline PET/CT for the detection of bone metastasis in prostate cancer: A systematic review and meta-analysis
por: Guo, Yu, et al.
Publicado: (2018)

Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and (18) F-choline PET/CT
por: Vees, Hansjörg, et al.
Publicado: (2012)

Dynamic (11)C-Choline PET / CT for the primary diagnosis of prostate cancer
por: Golan, Shay, et al.
Publicado: (2018)

Detection of lymph node metastases in patients with prostate cancer: Comparing conventional and digital [(18)F]‐fluorocholine PET‐CT using histopathology as a reference
por: Bjöersdorff, Mimmi, et al.
Publicado: (2022)

Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer
por: Evangelista, Laura, et al.
Publicado: (2021)

Impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous (18)F-choline PET/MRI for prostate cancer
por: Muehlematter, Urs J., et al.
Publicado: (2018)

Assessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with (18)F-Choline PET/CT in Prostate Cancer
por: Mathieu, Cédric, et al.
Publicado: (2015)

Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series
por: Sollini, Martina, et al.
Publicado: (2016)

Prognostic Value of (18)F-Choline PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radium-223
por: Filippi, Luca, et al.
Publicado: (2020)

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
por: Afshar-Oromieh, Ali, et al.
Publicado: (2013)

Lymph Node Staging with Choline PET/CT in Patients with Prostate Cancer: A Review
por: Skanjeti, Andrea, et al.
Publicado: (2011)

Imaging and Tissue Biomarkers of Choline Metabolism in Diffuse Adult Glioma: 18F-Fluoromethylcholine PET/CT, Magnetic Resonance Spectroscopy, and Choline Kinase α
por: Grech-Sollars, Matthew, et al.
Publicado: (2019)

Correction to: impact of time-of-flight PET on quantification accuracy and lesion detection in simultaneous (18)F-choline PET/MRI for prostate cancer
por: Muehlematter, Urs J., et al.
Publicado: (2018)

Initial Institutional Experience with 18F-Fluciclovine PET-CT in Biochemical Recurrence of Prostate Cancer
por: Farkas, Amy B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2f7ph01beip3h3hvfhnf5tot0r